2013美国内分泌医师协会糖尿病综合管理方案之血糖管理方案解读
被引量:2
摘要
2013年美国内分泌医师协会(AACE)与美国内分泌协会(ACE,注:ACE是AACE下属负责教育的分支机构,实际是一个协会)在AACE年会上共同发布了新版糖尿病综合管理流程图,该图包括糖尿病前期管理、血糖控制以及以患者为中心的超重和肥胖患者管理、心血管危险因素的纠正以及加用/强化胰岛素治疗的流程图,其中有关血糖管理部分见图1。
出处
《中国医学前沿杂志(电子版)》
2013年第8期36-39,共4页
Chinese Journal of the Frontiers of Medical Science(Electronic Version)
参考文献16
-
1Abrahamson MJ,Grunberger George,Barzilay JI. American Association of Clinical Endocrinology(AACE),AACE Comprehensive Diabetes Management Algorithm[J].{H}Endocrine Practice,2013,(02):327-336.
-
2Inzucchi SE,Bergenstal RM,Buse JB. American Diabetes Association(ADA)European Association for the Study of Diabetes(EASD).Management of hyperglycemia in type 2 diabetes:a patient-centered approach:position statement of the American Diabetes Association(ADA)and the European Association for the Study of Diabetes(EASD)[J].{H}DIABETES CARE,2012,(06):1364-1379.
-
3中国成人2型糖尿病HbA1c控制目标的专家共识[J].中华内分泌代谢杂志,2011,27(5):371-374. 被引量:124
-
4中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J]{H}中国糖尿病杂志,2012(20):s1-s37.
-
5Schernthaner G,Grimaldi A,DiMario U. GUIDE study:double-blind comparison of once-daily gliclazide MR and glimepiride in type2 diabetic patients[J].{H}European Journal of Clinical Investigation,2004,(08):535-542.
-
6UK Prospective Diabetes Study(UKPDS)Group. Intensive blood-glucose control with sulphonylureas or insulin compared with Conventional treatment and risk of complications in patients with type2 diabetes(UKPDS33)[J].{H}LANCET,1998,(9131):837-853.
-
7ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J].{H}New England Journal of Medicine,2008,(24):2560-2572.
-
8Jameson K,Dixon T,Mann R. Hypoglycaemia in type 2 diabetes[J].{H}DIABETIC MEDICINE,2008,(03):245-254.
-
9Pulizzi N. The place of sulfonylureas in the therapy for type 2 diabetes mellitus[J].{H}Metabolism-Clinical and experimental,2006,(5Suppl1):21-22.
-
10González-Ortiz M,Guerrero-Romero JF,Violante-Ortiz R. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patien ts with uncontrolled type 2 diabetes mellitus[J].{H}Journal of Diabetes and its Complications,2009,(06):376-379.
二级参考文献32
-
1中华医学会糖尿病学分会.中国2型糖尿病防治指南.中华内分泌代谢杂志,2008,24(2).
-
2Thompson C J, Cummings JF, Chalmers J, et al. How have patients reacted to the implications of the DCCT? Diabetes Care, 1996,19:876- 879.
-
3International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care ,2010,33:676-682.
-
4International Diabetes Federation. Global Guideline on Pregnancy and Diabetes. 2009, http://www.idf. org/webdata/docs/Pregnancy_EN_RTP. pdf.
-
5Oglesby AK, Secnik K, Barron J, et al. The association between diabetes related medical costs and glycemic control : a retrospective analysis. Cost Eft Resour Alloc ,2006,4 : 1-8.
-
6Dowell MA, Rozell B, Roth D, et al. Economic and clinical disparities in hospitalized patients with type 2 diabetes. J Nuts Scholarsh,2004,36 : 66-72.
-
7Bloomgarden ZY. A1C: recommendations, debates, and questions. Diabetes Care ,2009,32 : e141 -e147.
-
8Steffes M, Molitch M, Chavers B, et al. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Am Med Assoc, 2003, 290: 2159-2167.
-
9Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care,2000,2:21-29.
-
10Hayden MR. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes( UKPDS 33 ). Lancet, 1998,352 : 837- 853.
共引文献123
-
1陈清波.心血管急重症患者血糖波动异常的预后及血糖管理策略[J].医学信息(医学与计算机应用),2016,29(36):109-110.
-
2闫双通,母义明.2012美国老年糖尿病共识解读[J].中国医学前沿杂志(电子版),2013,5(5):53-56. 被引量:1
-
3宁光.HbA1C:临床应用中的几个问题[J].中华内分泌代谢杂志,2011,27(5):365-366. 被引量:6
-
4田慧.从指南到实践——浅谈老年糖尿病的诊治策略[J].中华老年多器官疾病杂志,2011,10(4):289-292. 被引量:3
-
5郑荣秀,刘戈力,鲍鹏丽,杨箐岩,魏莹,姜丽红,张姗姗,于阿莉,高芳芳.HbA1C检测在肥胖儿童中诊断筛查糖代谢紊乱的效果[J].中华内分泌代谢杂志,2011,27(9):746-748. 被引量:7
-
6杜婷婷,张建华,邵诗颖,张丹,石薇,律冉,余学锋.高血压人群中HbA_1C诊断糖尿病的应用[J].中华内分泌代谢杂志,2011,27(10):825-827. 被引量:2
-
7王连芹,吉训明,魏玉清,王玉,孔咏梅,李国锋,刘海花,王云,殷海清,李英毅,彭红兵,宁海春,李俊青.症状性脑动脉狭窄未行支架植入患者多类药物一体化治疗的研究[J].临床荟萃,2011,26(21):1841-1847. 被引量:6
-
8徐志勇.长效胰岛素或中效胰岛素联用口服降血糖药物治疗2型糖尿病的疗效和安全性比较[J].中国医师杂志,2012,14(1):127-129. 被引量:3
-
9郑郁,母义明.拜安时,HbA_(1c)监测的新选择[J].药品评价,2012(1):39-41.
-
10无,童南伟.中国成人2型糖尿病胰岛素促泌剂应用的专家共识[J].中华内分泌代谢杂志,2012,28(4):261-265. 被引量:41
同被引文献24
-
1杨文英.磺脲类药物应用专家共识[J].国外医学(内分泌学分册),2004,24(4):255-259. 被引量:75
-
2贺占举,陈铭,张凯,金杰.彩色多普勒超声检查在血管性勃起功能障碍诊断中的应用[J].中华男科学杂志,2006,12(1):62-65. 被引量:20
-
3杨宝峰.药理学[M].8版.北京:人民卫生出版社,2013:1-484.
-
4Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[ J ]. N Engl J Med ,2010,362 : 1090 - 1101.
-
5XuY, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[ J]. JAMA ,2013,310:948 - 958.
-
6Gangji AS, Gukiermen T, Gerstein HC,et al. A systematic review and recta-analysis of hypoglycemia and cardiovascular events:a comparison of glyburide with other secretagogues and with insulin [ J ]. Diabetese, 2007,30:389 - 394.
-
7宋玉香.格列本脲治疗2型糖尿病48例疗效分析[J].临床合理用药杂志,2010,3(7):67-67. 被引量:4
-
8陈艳梅.优降糖致低血糖症临床分析[J].中国实用医药,2010,5(17):99-100. 被引量:1
-
9李雅玲,李珊,李富华.糖尿病治疗药物的研究进展[J].临床合理用药杂志,2010,3(11):140-141. 被引量:16
-
10杨阳,陈斌,王鸿祥,马逸,胡剑麟,翁一鸣,胡凯,韩银发,王益鑫,黄翼然.阴茎疲软状态下海绵体动脉收缩期最大流速对动脉性ED的预测作用初探[J].中国男科学杂志,2010,24(7):44-47. 被引量:3
二级引证文献6
-
1杜婷婷,陈国良,方武宏,韩尚河,那一凡,刘铮.格列本脲衍生物的设计、合成与降血糖活性[J].沈阳药科大学学报,2015,32(12):937-940. 被引量:1
-
2李飞玲,杨小丽,李俊波,刘学慧,杨金香.共振瑞利散射光谱法测定格列本脲[J].长治医学院学报,2016,30(1):13-15.
-
3李霞,徐升兵.中西药复方制剂再评价的有关问题探讨[J].药物评价研究,2017,40(5):577-585. 被引量:10
-
4温富星,邱晓川,马文峰,曾淑华.彩色多普勒超声联合药物注射在ED诊断中的应用价值探讨[J].基层医学论坛,2019,23(29):4235-4236. 被引量:2
-
5王丹,孙敬蒙,张晓晨,白彩萍,张炜煜.格列本脲类脂质体片的释药机制及药效学研究[J].西北药学杂志,2019,34(6):788-791.
-
6段立志,刘波,张何英,尚国爱,赵海霞.内蒙古及河北地区2型糖尿病患者勃起功能障碍的患病率[J].临床与病理杂志,2019,39(11):2437-2443. 被引量:3
-
1金晖,邱宏玲,蔡若男,徐琳,孙子林.瑞格列奈与胰岛素联合二甲双胍对初发2型糖尿病的疗效与安全性研究[J].临床合理用药杂志,2011,4(07X):10-11. 被引量:2
-
2熊筱璐,朱大龙.二甲双胍的心血管保护作用[J].药品评价,2015,12(1):36-39. 被引量:3
-
3郭艺芳.2008年美国临床内分泌医师协会最新糖尿病前期治疗指南[J].临床荟萃,2010,25(22). 被引量:8
-
4无,庄稼英(编译).AACE糖尿病临床综合管理指南[J].糖尿病天地(临床),2011(4):157-162.
-
5阿帕维安,无.肥胖的治疗该归哪个科室管?[J].糖尿病天地(临床),2013,7(4):174-174.
-
6谭志学,陈香.糖尿病前期的诊断和管理——ACE/AACE共识声明[J].药品评价,2009(11):439-445. 被引量:6
-
7AACE、ATA联合发布甲减诊治指南[J].药学与临床研究,2012,20(5):449-449.
-
8莫吉斯,徐赫男(编译).AACE/ADA关于住院病人血糖控制的共识[J].糖尿病天地(临床),2009,3(6):246-255. 被引量:3
-
9谷伟军,陆菊明.2009年AACE/ADA住院患者的血糖控制共识 病情不同,血糖控制目标有异[J].中国社区医师,2010(2):4-4.
-
10代谢综合征(MS)/胰岛素抵抗综合征(IRS)诊断标准[J].疑难病杂志,2006,5(2):96-96. 被引量:7